Investing

Investing Cash Flow

Zimmer Biomet Holdings Investing Cash Flow increased by 50.6% to -$159.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from -$106.00M to -$159.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 40.7% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026

How to read this metric

A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.

Detailed definition

This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...

Peer comparison

Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.

Metric ID: net_cash_from_investing

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$109.90M-$125.20M-$146.20M-$81.10M-$243.20M-$85.20M-$112.50M-$149.40M-$243.10M-$165.60M-$220.80M-$195.00M-$247.00M-$154.90M-$291.20M-$106.00M-$1.38B-$163.30M-$322.00M-$159.00M
QoQ Change-13.9%-16.8%+44.5%-199.9%+65.0%-32.0%-32.8%-62.7%+31.9%-33.3%+11.7%-26.7%+37.3%-88.0%+63.6%<-999%+88.2%-97.2%+50.6%
YoY Change-121.3%+31.9%+23.1%-84.2%+0.0%-94.4%-96.3%-30.5%-1.6%+6.5%-31.9%+45.6%-460.5%-5.4%-10.6%-50.0%
Range-$1.38B-$81.10M
CAGR+8.1%
Avg YoY Growth-55.0%
Median YoY Growth-20.5%

Frequently Asked Questions

What is Zimmer Biomet Holdings's investing cash flow?
Zimmer Biomet Holdings (ZBH) reported investing cash flow of -$159.00M in Q1 2026.
How has Zimmer Biomet Holdings's investing cash flow changed year-over-year?
Zimmer Biomet Holdings's investing cash flow decreased by 50.0% year-over-year, from -$106.00M to -$159.00M.
What is the long-term trend for Zimmer Biomet Holdings's investing cash flow?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's investing cash flow has grown at a 40.7% compound annual growth rate (CAGR), from -$503.60M to -$1.98B.
What does investing cash flow mean?
The net amount of cash spent on or received from investing activities.